Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

ON-013100 is a cell cycle inhibitor.1 It induces cell cycle arrest at the G2/M phase in Granta 519 mantle cell lymphoma cells when used at a concentration of 1 µM. ON-013100 decreases levels of murine double minute 2 (MDM2), cyclin D1, and cyclin dependent kinase 4 (Cdk4) and increases levels of cyclin B1 in Granta 519 cells. It induces apoptosis in Granta 519 cells when used at a concentration of 0.01 µM. ON-13100 (1 or 10 µM), in combination with doxorubicin (Item No. 15007) or vincristine (Item No. 11764), induces cytotoxicity in Granta 519 and Z-138C mantle cell lymphoma cells.
WARNING This product is not for human or veterinary use.
1. Evaluation of novel cell cycle inhibitors in mantle cell lymphoma. Oncogene 26(38), 5635-5642 (2007).